« Advanced Modelling Methods For Health Economic Evaluation | Main | Oxford University Short Courses in Health Economics in Hong Kong and Shenzhen »
September 26, 2007
PhD in Pharmaceutical Outcomes Research and Policy: University of Washington, Department of Pharmacy
Location: Seattle, Washington, USA
Application Deadline: 15 January 2007
Date of Commencement: 26 September 2007
Type of Course: Full-time
Class size: Average size of class intake is 3-4
E-mail: penny@u.washington.edu
Website: http://depts.washington.edu/porpp/gradpage.html
Program Description: The University of Washington created the Pharmaceutical Outcomes Research and Policy Program (PORPP) in 1995 to consolidate and coordinate research and training efforts among a number of faculty. Program faculty and professional staff provide medical facilities, health insurance providers pharmaceutical and device companies and governmental agencies with analyses on the safety and cost-effectiveness of prescription drugs in order to achieve a better understanding of the risks and benefits of medical and pharmaceutical interventions. PORPP has helped the UW become a nationally recognized center for pharmacoepidemiology, pharmacoeconomics, and pharmaceutical policy research.
Pharmaceutical outcomes research employs economic and epidemiologic methods to evaluate clinical outcomes, morbidity, quality of life, and cost-effectiveness. The graduate program in pharmaceutical outcomes research and policy trains students in economic evaluation, pharmacoepidemiology, health services research, and pharmaceutical policy formulation and evaluation.
Career Opportunities
Graduate training leading to a degree in Pharmaceutical Sciences prepares students for career opportunities in:
- Teaching and research at colleges and universities.
- Safety and economic evaluation of products in the pharmaceutical, biotechnology and medical device industries.
- Policy analysis for professional associations, health care insurance providers, and governmental agencies.
- Management within hospitals, managed care organizations and programs concerned with reimbursement for pharmaceuticals and other medical technologies.
